Patents by Inventor Chuan Shih

Chuan Shih has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110105793
    Abstract: The present invention provides a method for separating an amide from an amino acid ionic liquid. The method includes the step of providing a polar solvent and an extracting agent to the amino acid ionic liquid, so as to separate the amide from the amino acid ionic liquid. In the method of the present invention, there is no need to add ammonium for neutralization, such that no byproduct, ammonium sulfate, is formed. In addition, after the amide is separated from the amino acid ionic liquid, the amino acid ionic liquid can be recycled.
    Type: Application
    Filed: December 14, 2009
    Publication date: May 5, 2011
    Applicant: CHINA PETROCHEMICAL DEVELOPMENT CORPORATION
    Inventors: Cheng-Fa Hsieh, Chien-Chuan Shih, Chi-Yuan Chen
  • Patent number: 7767674
    Abstract: The present invention provides kinase inhibitors of Formula I:
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: August 3, 2010
    Assignee: Eli Lilly and Company
    Inventors: Tiechao Li, Mark Andrew Pobanz, Chuan Shih, Yong Wang, Boyu Zhong, Jesus Andres Blas, Alfonso De Dios, Beatriz Lopez De Uralde-Garmendia, Luisa Maria Martin Cabrejas
  • Publication number: 20100022529
    Abstract: The present invention provides amidophenoxyindazole compounds useful in the treatment of cancer.
    Type: Application
    Filed: July 15, 2009
    Publication date: January 28, 2010
    Inventors: Tiechao LI, Mark Andrew POBANZ, Chuan SHIH, Zhipei WU, Wei Jennifer YANG, Boyu ZHONG
  • Patent number: 7652015
    Abstract: The present invention provides kinase inhibitors of Formula (I). Wherein R1, R2, X and Z are as described herein, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 25, 2006
    Date of Patent: January 26, 2010
    Assignee: Eli Lilly and Company
    Inventors: Jolie Anne Bastian, Jesus Andres Blas de Blas, Alfonso De Dios, Kevin John Hudziak, Tiechao Li, Beatriz López De Uralde-Garmendia, Mary Margaret Mader, Michael Ray Myers, Mark Andrew Pobanz, Chuan Shih, Boyu Zhong
  • Publication number: 20100001664
    Abstract: An illuminating fabric product includes an elongated fabric ribbon adapted to be selectively folded to form a decorative fabric product, and a light string longitudinally extended along the fabric ribbon, wherein the light string includes a power supply, a plurality of spacedly apart illuminators provided at the fabric ribbon, and an electric wire electrically linked the illuminators with the power supply. When the light string is folded within the fabric ribbon to form the decorative fabric product, the illuminators are adapted for generating a light effect to produce an illuminating effect for the decorative fabric product.
    Type: Application
    Filed: February 25, 2009
    Publication date: January 7, 2010
    Inventor: Shu-Chuan Shih
  • Publication number: 20090318443
    Abstract: The present invention provides kinase inhibitors of Formula I.
    Type: Application
    Filed: July 27, 2009
    Publication date: December 24, 2009
    Inventors: Rosanne Bonjouklian, Chafiq Hamdouchi Hamdouchi, Chuan Shih, Alfonso De Dios, Miriam Filadelfa Del Prado, Carlos Jaramillo Aguado, Pramila Kotiyan, Mary Margaret Mader, Sheila Pleite Selgas, Concepcion Sanchez-Martinez
  • Publication number: 20090226643
    Abstract: An illuminating decorative bow includes an elongated fabric ribbon being folded to form a decorative bow and an illuminating arrangement. The illuminating arrangement includes a light string longitudinally extended along the fabric ribbon and folded with fabric ribbon to form the decorative bow, wherein the light string includes a plurality of illuminating elements spacedly provided along the fabric ribbon for producing an illuminating effect for the decorative bow.
    Type: Application
    Filed: March 3, 2009
    Publication date: September 10, 2009
    Inventor: Shu-Chuan Shih
  • Patent number: 7582638
    Abstract: The present invention provides kinase inhibitors of Formula (I) wherein R1, R2, and X are as described herein, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 23, 2006
    Date of Patent: September 1, 2009
    Assignee: Eli Lilly and Company
    Inventors: Alfonso De Dios, Cristina Garcia-Paredes, Beatriz López de Uralde Garmendia, Mary Margaret Mader, Mark Andrew Pobanz, Chuan Shih, Boyu Zhong
  • Patent number: 7582652
    Abstract: The present invention provides kinase inhibitors of Formula I.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: September 1, 2009
    Assignee: Eli Lilly and Company
    Inventors: Rosanne Bonjouklian, Chafiq Hamdouchi, Chuan Shih, Alfonso De Dios, Miriam Filadelfa del Prado, Carlos Jaramillo Aguado, Pramila Kotiyan, Mary Margaret Mader, Sheila Pleite Selgas, Concepcion Sanchez-Martinez
  • Publication number: 20090217304
    Abstract: According to different VID/PIDs stored in a device descriptor of a USB composite device, various functions and corresponding drivers are assigned and switched. Therefore, the switches of functions are achieved without detaching and attaching the USB composite device. Possible problems while switching operation systems of different platforms are overcome. And the high cost in embedding various drivers into a mainframe is reduced.
    Type: Application
    Filed: May 5, 2008
    Publication date: August 27, 2009
    Inventors: Po-Chuan Shih, Chen-Pang Hsu
  • Patent number: 7547691
    Abstract: The present invention provides compounds of Formula I: useful in the treatment of cancer and inflammatory diseases.
    Type: Grant
    Filed: November 15, 2006
    Date of Patent: June 16, 2009
    Assignee: Eli Lilly and Company
    Inventors: Karl Robert Dahnke, Ho-Shen Lin, Michael Enrico Richett, Chuan Shih, Q May Wang, Bo Zhang
  • Publication number: 20090039255
    Abstract: The invention relates to a method for detecting the presence of hydrocarbons near an unmanned offshore oil platform. The method steps include monitoring reflected atmospheric and thermal radiation, detecting the presence of hydrocarbons, and generating an alert based on the presence of hydrocarbons.
    Type: Application
    Filed: August 7, 2008
    Publication date: February 12, 2009
    Applicant: SCHLUMBERGER TECHNOLOGY CORPORATION
    Inventors: Albert Ballard Andrews, Wei-Chuan Shih, Matthew Clayton, Oliver C. Mullins
  • Publication number: 20090036445
    Abstract: The present invention provides kinase inhibitors of Formula I.
    Type: Application
    Filed: January 25, 2005
    Publication date: February 5, 2009
    Inventors: Rosanne Bonjouklian, Chafiq Hamdouchi, Chuan Shih, Alfonso De Dios, Miriam Filadelfa del Prado, Carlos Jaramillo Aguado, Pramila Kotiyan, Mary Margaret Mader, Sheila Pleite Selgas, Concepcion Sanchez-Martinez
  • Publication number: 20080306082
    Abstract: The present invention provides compounds of Formula I: useful in the treatment of cancer and inflammatory diseases.
    Type: Application
    Filed: November 15, 2006
    Publication date: December 11, 2008
    Inventors: Karl Robert Dahnke, Ho-Shen Lin, Michael Enrico Richett, Chuan Shih, Q May Wang, Bo Zhang
  • Publication number: 20080306068
    Abstract: The present invention provides kinase inhibitors of Formula I:
    Type: Application
    Filed: June 15, 2005
    Publication date: December 11, 2008
    Applicant: Eli Lilly and Company
    Inventors: Tiechao Li, Mark Andrew Pobanz, Chuan Shih, Yong Wang, Boyu Zhong, Jesus Andres Blas, Alfonso De Dios, Beatriz Lopez De Uralde-Garmendia, Luisa Maria Martin Cabrejas
  • Publication number: 20080275056
    Abstract: The present invention provides kinase inhibitors of Formula (I) wherein R1, R2, and X are as described herein, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 23, 2006
    Publication date: November 6, 2008
    Inventors: Alfonso De Dios, Cristina Garcia-Paredes, Beatriz Lopez Uralde Garmendia, Mary Margaret Mader, Mark Andrew Pobanz, Chuan Shih, Boyu Zhong
  • Publication number: 20080269244
    Abstract: The present invention provides kinase inhibitors of Formula (I). Wherein R1, R2, X and Z are as described herein, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 25, 2006
    Publication date: October 30, 2008
    Inventors: Jolie Anne Bastian, Jesus Andres Blas de Blas, Alfonso De Dios, Kevin John Hudziak, Tiechao Li, Beatriz Lopez De Uralde-Garmendia, Mary Margaret Mader, Michael Ray Myers, Mark Andrew Pobanz, Chuan Shih, Boyu Zhong
  • Patent number: 7250430
    Abstract: The present invention provides antineoplastic compounds of the formula: and antineoplastic methods.
    Type: Grant
    Filed: June 6, 2006
    Date of Patent: July 31, 2007
    Assignee: Eli Lilly and Company
    Inventors: Cora Sue Grossman, Philip Arthur Hipskind, Ho-Shen Lin, Karen Lynn Lobb, Beatriz Lopez de Uralde Garmendia, Jose Eduardo Lopez, Mary Margaret Mader, Michael Enrico Richett, Chuan Shih, Alfonso De Dios
  • Publication number: 20070060806
    Abstract: The present invention relates to the use of Raman spectroscopy for quantitative, non-invasive transcutaneous measurement of blood analytes, such as glucose. Raman spectroscopy is used to measure glucose transcutaneously, in patients whose blood glucose levels were monitored. Raman spectra were collected transcutaneously along with glucose reference values provided by standard capillary blood analysis. A partial least squares calibration was created from the data from each subject and validated using leave-one-out cross validation.
    Type: Application
    Filed: April 27, 2006
    Publication date: March 15, 2007
    Inventors: Martin Hunter, Annika Enejder, Thomas Scecina, Michael Feld, Wei-Chuan Shih
  • Publication number: 20070049809
    Abstract: The present invention relates to systems and methods for the measurement of analytes such as glucose. Raman and reflectance spectroscopy are used to measure a volume, of material such as a blood sample or tissue within a subject and determine a concentration of a blood analyte based thereon. The present invention further relates to a calibration method, constrained regularization (CR), and demonstrates its use for analyzing spectra including, for example, the measurement glucose concentrations using transcutaneous Raman spectroscopy.
    Type: Application
    Filed: July 24, 2006
    Publication date: March 1, 2007
    Inventors: Kate Bechtel, Wei-Chuan Shih, Michael Feld